Crossmark

The efficacy of prophylactic metoclopramide in preventing nausea and vomiting in patients with acute pain treated with intravenous tramadol: a randomized double-blinded, placebo-controlled trial

Crossref DOI link: https://doi.org/10.1186/s13104-023-06395-y

Published Online: 2023-07-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sriwiset, Haruethai

Lokeskrawee, Thanin

Patumanond, Jayanton

Wongyikul, Pakpoom

Phinyo, Phichayut
Funding

Funding for this research was provided by:

Lampang Hospital
License Information

Text and Data Mining valid from 2023-07-27

Version of Record valid from 2023-07-27
More Information

Article History

Received: 15 November 2022

Accepted: 18 June 2023

First Online: 27 July 2023

Declarations

:

: The study protocol was registered in Thai Clinical Trials Registry (TCTR) [TCTR20220525001] in 21 October 2021. The Institutional Review Board of Lampang Hospital approved the study protocol (CERT NO.103/64). All patients provided written informed consent prior to study inclusion and randomization. all methods were performed in accordance with the Declaration of Helsinki.

: None of individual person’s data was used in this study.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below